GREY:SLHGF - Post by User
Comment by
ScarletSpideron Oct 28, 2020 12:27am
161 Views
Post# 31793829
RE:RE:RE:GLOBE AND MAIL- Bruce Campbell
RE:RE:RE:GLOBE AND MAIL- Bruce Campbell
this company isnt a telemedicine company that isnt this company's primary business it is a vehicle and tool to continue to operate during the pandemic so there is no competition here. This however is an AI platform business that uses its software in the medical cannabis field and as there are more analytic based companies regardless of sector yes they will have more people in the field but clients are clients and this is two prong one is with those who have paid subscriptions and are getting counseling at the clinics. As long as the service is really good and people feel they are getting really good care they will continue on and the payments are mostly handled through Medicare and Medicaid which are insurance of private organizations and government along with what the individuals pay to have their coverages so this is a very person to person based business with the compassionate human touch. The other part of this is for those who the company is hired to crunch numbers and data now if the company moves into supplying developed products that may create a bi directional loyalty. Whether things will become on the bottom line basis with solid AI providers may become a reality but there are those who establish such a trusting and working relationship they dont chance it with anyone new. And of course acquisitions. No matter what everything is about branding providing high quality and dependable service where those who pay for it feel it is excellent value for their money and no this doesnt necessarily mean the lower costs is it. The cbd medical side is great because it takes a lot of knowledge and effort to develop effective treatments so it isnt simply edibles etc which become super competitive and was the primary reason for the sector collapse too much cannabis available and not in a very specialized way...the recreational side is not one I would focus on that is why I came to this one the medical treatment one. Overall I feel fully confident this company will continue to do extremely well and grow but let's see where things go. The pandemic should really be a no issue over here actually and another reason I invested here. With the use of telehealth no reason this doesnt continue to grow and on the research side all about systematized data that will always flow with the amount of time needed for the studies and their results. Excellent potential still moving forward.